Non-invasive shockwave therapy that accelerates healing and boosts practice success—trusted by top providers nationwide. This page is for providers.
If you are a patient seeking treatment please visit https://softwavetrt.com/providers/ SoftWave TRT, LLC is a medical technology company that is developing advanced solutions specializing in shockwave therapy for better patient healing.
Founded in 2004 and headquartered in Alpharetta, GA, SoftWave TRT is committed to the scientific advancement of tissue healing and regeneration and the developme
nt of the most effective innovations to improve the quality of lives globally. German-engineered with superior quality, it is used worldwide in the healthcare fields of orthopedics, traumatology, wound care, aesthetics, and urology. SoftWave technology is trusted by the top major medical research centers in the U.S. and worldwide, with over 300 published studies of the technology supporting its effectiveness. It has a strong international presence with its German manufacturing partner and is internationally recognized by the International Society for Medical Shockwave Technology (ISMST).
06/04/2026
Happy National Championship Monday! 🏀
An NBA player and a UNLV basketball player walked into Heather Linden's clinic and expected the worst. They'd used other shockwave devices before and figured they wouldn't be able to play that night.
Both left feeling great — and both returned to their sport that same evening.
"The athletes tolerate it way better."
— Heather Linden, Sports Medicine & Regenerative Medicine Provider
This is what SoftWave does. Non-invasive, well-tolerated, and built for athletes who can't afford to sit out.
Women’s sexual health is finally getting the attention it deserves—and the conversation is evolving.
In her recent discussion with Mel Robbins, Dr. Rachel Rubin emphasizes that treating GSM and pelvic health conditions often requires an “all of the above” approach. Systemic HRT, local vaginal therapy, and more—all working together.
For providers, that also means expanding the toolkit.
SoftWave TRT is being added as a non-invasive, non-pharmacological option that can complement existing treatment plans and support tissue healing at the cellular level.
Why it’s resonating:
• No downtime for patients
• Works alongside hormone therapies like DHEA and estrogen
• Designed to support natural healing responses
If you’re looking to elevate your outcomes in women’s health, this is a conversation worth having.
This National Foot Health Month, we want to share a story that stopped us in our tracks. 🦶
Dr. Mark LeVee was in a serious accident when a golf cart severed his left foot nearly completely. After a heroic surgery to save it, he was left with one recovering foot — and another crippled by severe arthritis. He thought his career as a chiropractor was finished.
Then he was introduced to SoftWave. He became his own first patient, and the results were so remarkable that he was actually upset — upset that no other doctor had ever told him this technology existed.
"SoftWave gave me my life back — and after it gave my life back to me, it gave me a whole new career."
Dr. LeVee is now a SoftWave provider and regional trainer, dedicated to bringing this technology to as many patients as possible.
If you're a provider curious about what SoftWave can do for your patients, book a call with our team today: https://bit.ly/4bNfsuI
31/03/2026
As National Athletic Training Month comes to a close, we want to take a moment to recognize the incredible athletic trainers and clinicians who dedicate themselves to keeping athletes healthy every single day.
At SoftWave, supporting that mission is what drives us. Our non-invasive technology is built to work alongside the professionals who make recovery possible — efficiently, effectively, and at every phase of healing.
Thank you to every AT out there. The work you do matters. 💙
25/03/2026
Before any player steps on the field Opening Day, thousands of hours of preparation happen behind the scenes — and recovery is a big part of it.
SoftWave's FDA 510(K) cleared technology uses shockwave therapy to target inflammation at the source, helping athletes heal faster and perform at their best when it counts.
Trusted by pro teams. Built for the long season. ⚾
19/03/2026
Attending AAOM OTX 2026 this week? 🌊
Come find us at Booth #11 at the Hilton Pensacola Beach, March 18-21, and discover why SoftWave is the ONLY Broad-Focused Electrohydraulic Shockwave —
FDA-cleared and safety engineered.
19/03/2026
We're at SOLEutions 2026!
📍 Hilton Nashville Green Hills, March 18-21. Stop by to learn how SoftWave's FDA-cleared shockwave technology is changing the game in predictable healing and practice growth.
16/03/2026
March Madness pushes athletes to their limits.
Recovery is what keeps them in the game.
SoftWave therapy helps activate the body’s natural healing response, supporting recovery from musculoskeletal injuries and helping patients get back to doing what they love.
12/03/2026
We'll be in Boston this weekend for the ASMST Annual Summit.
Looking forward to connecting with clinicians and researchers advancing shockwave medicine and the future of regenerative recovery.
See you there!
27/02/2026
Insights from a professional training environment highlight what matters most: treatments that fit into real clinical workflows and demanding schedules.
We appreciate the opportunity to work alongside organizations that operate at a high level.
SoftWave is a Proud Partner of the Los Angeles Rams.
25/02/2026
SoftWave is honored to sponsor the 2026 ASMST Summit, March 13–15 in Boston. We’re proud to support the clinical and scientific community advancing evidence-based shockwave care.
Weeks 8–12 are when structural recovery stabilizes and lasting outcomes appear. Regenerative care often seems inconsistent only because it’s evaluated on symptom timelines instead of biologic timelines. Correct expectation alignment improves both compliance and results.
Be the first to know and let us send you an email when SoftWave TRT posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Tissue Regeneration Technologies (TRT) is a worldwide leader in medical shockwave technology. TRT manufactures and distributes various shockwave (ESWT) devices including the unfocused LithoGold lithotripter, UroGold, DermaGold, and OrthoGold. These medical devices are used in Urology, Orthopedics, Sports Medicine, Wound care, and Cardiology. In 2006, TRT has proven that its patented SoftWave technology has a strong regenerative effect on tissue including skin, bones, nerves, and heart.
The patented softwave technology uses various lens configurations to produce pressure waves. These waves have a characteristic pressure profile of short rise-times reaching high amplitudes (comparable to a sonic boom). The pressure waves can be shaped through a reflector, which enables the transmission of either highly-focused Shockwaves for use on urinary stones or non-union fractures, or soft-focused pressure waves (i.e., SoftWaves) for most soft tissue indications.
TRT’s patented SoftWave technology is distinguished from competitors’ shockwave technology in that TRT uses a patented parabolic (as opposed to an ellipsoid) reflector in the therapy head, which allows delivery of unfocused waves of acoustic energy over a broad target area. TRT’s SoftWave technology generates less pain, has a higher efficacy rate, and has a lower re-treatment rate than competitors’ high-energy, focused shockwave systems. TRT is the first company to discover that “softwaves” have the same or better clinical benefit as high-energy focused Shockwaves for most medical conditions. Following this discovery, TRT further developed the idea into a useful format, and secured patents protecting its inventions.
The advantages of SoftWave technology include the following benefits: (1) treatments do not require anesthesia; (2) larger surfaces, such as wounds, can be treated faster and easier than with competing shockwave devices.
TRT currently has product lines developed for the treatment of six distinct areas of care:
LithoGold – Lithotripsy and urology indications
OrthoGold – Orthopedic indications
DermaGold – Wound care indications
CardioGold – Cardiac and vascular indications
VetGold – Veterinary indications
UroGold – Urologic indications
The OrthoGold has been FDA cleared for connective tissue activation and registered for increased blood flow and pain relief. The DermaGold has been FDA cleared to treat diabetic ulcers.
